Every 8-K that PUBLIC COMPANY MGMT CORP (PCMC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PCMC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PCMC filings page.
Public Company Management Corporation agreed to acquire Physicians Capital Management Corporation through a share exchange that will shift control and change its business focus. PCMC will issue 68,566,368 shares of common stock and 24,913,918 preferred shares, including 1,000,000 Series A Voting Preferred, 15,942,612 Series B‑1, and 7,971,306 Series B‑2, in exchange for all Physicians shares.
The exchange shares are expected to represent about 80% of PCMC’s common stock on a fully diluted, as‑converted basis after closing, leaving existing PCMC holders with about 20%. Closing is targeted for the third quarter of 2026, subject to customary conditions and effectiveness of a Form S‑4 registration statement.
After closing, PCMC plans to cease being a shell company and focus on healthcare real estate, owning and developing income‑producing medical offices and outpatient facilities under long‑term triple‑net leases. Conrad Ivie, MD, is expected to gain voting control through Series A preferred and become Chief Executive Officer, with a board majority designated by Physicians.
Public Company Management Corporation amended its Articles of Incorporation to confirm its authorized capital and give the board more flexibility over preferred stock. The amendment restates Article 4 to authorize 500,000,000 shares of common stock and 50,000,000 shares of preferred stock, each with $0.001 par value.
The board now has “blank-check” authority to create one or more series of preferred stock and set their specific rights and preferences by board resolution and a Certificate of Designation filed under Nevada law. The amendment was approved by holders of a majority of the voting power on February 28, 2026 and became effective when filed with the Nevada Secretary of State on April 13, 2026.
Public Company Management Corporation is amending and restating Article 4 of its Articles of Incorporation to confirm authorized capital of 550,000,000 shares, consisting of 500,000,000 shares of common stock and 50,000,000 shares of preferred stock, each with $0.001 par value.
The Board is expressly authorized to create one or more series of preferred stock and set their specific rights and preferences under Nevada law. A stockholder holding 23,946,307 common shares, or about 70.3% of voting power, approved the change by written consent. The amendment will take effect after a Schedule 14C information mailing and subsequent Nevada filing and does not by itself issue any new shares.
Public Company Management Corporation has signed a non-binding letter of intent to acquire all of the stock of Physicians Capital Management Corporation, a healthcare facilities owner that leases properties under long-term net leases. The deal is expected to be a stock-for-stock business combination that would make Physicians a wholly owned subsidiary or equivalent.
The contemplated exchange ratio is structured so former Physicians shareholders would own about 80% of PCMC’s equity (voting and economic, fully diluted) after closing, with existing PCMC holders retaining about 20%, before any reverse split. PCMC, currently a reporting shell company, expects the transaction to be treated as a business combination related shell company transaction and a potential change of control, requiring a “Super 8-K” with Form 10-level disclosure after closing.
The LOI is largely non-binding and subject to detailed conditions, including satisfactory due diligence, audited Physicians financials for 2024 and 2025, negotiation and execution of a definitive agreement, shareholder and third-party approvals, and agreement on post-closing board and management roles, including appointing Conrad Ivie, M.D. as Chairman and CEO of PCMC at closing. Physicians and its controlling shareholder have agreed to a 90-day exclusivity period with a no-shop covenant, while both sides bear their own transaction expenses.